By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Medinol Ltd. 

Tel Aviv      Israel
Phone: N/A Fax:


Company News
Medinol Ltd. Announces Outstanding Results In A Randomized Trial Of A New Drug Eluting Stent 5/17/2016 8:23:35 AM
Medinol Ltd. U.S. Commercializes Novel Coronary Stent 12/1/2015 8:56:26 AM
Medinol Ltd. Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES Coronary Stent System 9/23/2015 11:19:18 AM
Ariad Pharmaceuticals, Inc. (ARIA) And Medinol Ltd. Announce Initiation Of Two Registration Trials Of The Nirsupreme™ Ridaforolimus-Eluting Stent For Use In Coronary Artery Disease 1/14/2014 8:38:43 AM
Medinol Ltd. Goes After Johnson & Johnson (JNJ)'s Cordis Corporation (JNJ) in Stent Patent War 8/28/2013 7:55:07 AM
Olympus Medical Systems Corp. in Collaboration with Medinol Ltd.; Announces the Release of the X-Suit NIR, a Biliary Metallic Stent Featuring Exceptional Anatomic Conformability 3/19/2009 7:46:56 AM
Hydromer, Inc. (HYDI) and Medinol Ltd. Enter Into a Coating Services and Supply Agreement for Stent Placement Catheters 9/3/2008 10:20:48 AM
Medinol Ltd. Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System 5/12/2008 7:17:52 AM
Cordis Corporation (JNJ) Signs Definitive Agreement with Medinol Ltd. for Global Distribution of Bare Metal Stents 5/23/2007 12:41:32 PM
Ariad Pharmaceuticals, Inc. (ARIA) Announces Collaboration With Medinol Ltd., Stent Technology Leader, To Develop AP23573 Drug-Delivery Stents10/19/2005 5:12:34 PM